Our lab specializes in developing innovative skin cancer prevention strategies and improving the dermatologic care patients receive. Main Research Areas: Innovative technology for cancer prevention, shared decision-making for older adults, equality & Diversity in medicine.

Our research focuses on the clinical development of novel therapeutics and clinical trials for rare monogenic diseases: Epidermolysis Bullosa and Basal Cell Nevus Syndrome. We use pre-clinical mouse models, epidemiology, genomics and investigator-initiated clinical trials to identify new treatments for our patients.

Our lab uses next generation sequencing technologies to investigate genetic and molecular alterations associated with skin cancer and skin diseases. Using genetic and molecular data obtained from patients, we predict and develop new therapeutics for a variety of skin disorders. Our ultimate goal is to utilize molecular information to manage and treat patients with dermatologic disorders. 

lab research interests: Extracellular matrix in carcinoma invasion, extracellular matrix in development, and extracellular matrix in epithelial adhesion.